NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+1-609-5538887
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
NephroGenex (OTCMKTS:NRXGQ) Frequently Asked Questions
What is NephroGenex's stock symbol?
NephroGenex trades on the OTCMKTS under the ticker symbol "NRXGQ."
Has NephroGenex been receiving favorable news coverage?
Media stories about NRXGQ stock have trended somewhat positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. NephroGenex earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the healthcare company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the stock's share price in the near term.
What other stocks do shareholders of NephroGenex own?
Who are NephroGenex's key executives?
NephroGenex's management team includes the folowing people:
- John P. Hamill CPA, Chief Executive Officer, Chief Financial Officer
How do I buy shares of NephroGenex?
Shares of NRXGQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NephroGenex's official website?
How can I contact NephroGenex?
NephroGenex's mailing address is PO Box 400, JAMISON, PA 18929-0400, United States. The healthcare company can be reached via phone at +1-609-5538887.
MarketBeat Community Rating for NephroGenex (OTCMKTS NRXGQ)
MarketBeat's community ratings are surveys of what our community members think about NephroGenex and other stocks. Vote "Outperform" if you believe NRXGQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRXGQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
